| Pharmaceutical applications of cyanobacteria—A review S Vijayakumar, M Menakha Journal of Acute Medicine 5 (1), 15-23, 2015 | 225 | 2015 |
| Bioactive potential of seagrass extracts against dengue fever mosquito S Vijayakumar, M Manakha, A Anderson, K Lingakumar International Journal of Microbiology & Parasitology 1 (1), 1-10, 2014 | 9 | 2014 |
| In silico prediction of drug molecule from Ipomoea sepiaria against Type 2 diabetes M Menakha, M Sangeetha, P Mani, MS Al-Aboody, R Vijayakumar Prog Med Sci 3 (1), 9, 2018 | 7 | 2018 |
| Molecular docking of bioactive compounds from Piper plants against secreted aspartyl proteinase of Candida albicans causing oral candidiasis P Mani, M Menakha, MS Al-Aboody, W Alturaiki, R Vijayakumar Int J Pharm Clin Res 8 (10), 1380-9, 2016 | 7 | 2016 |
| Prediction of new cyanobacterial drug for treating lung cancer S Vijayakumar, M Menakha Biomedicine & Aging Pathology 4 (1), 49-52, 2014 | 6 | 2014 |
| Molecular insights of newly identified potential peptide inhibitors of hypoxia inducible factor 1α causing breast cancer D Manimaran, S Ghanendra, M Sridhar, J Kaliaperumal, S Muniyaraj, ... Journal of Molecular Structure 1177, 558-563, 2019 | 5 | 2019 |
| Pharmaceutical applications of cyanobacteria—a review. J Acute Med 5 (1): 15–23 S Vijayakumar, M Menakha | 5 | 2015 |
| Insilico prediction of anticancer cyanobacterial drug from Nostoc M Sangeetha, M Menakha, S Vijayakumar Biomedicine & Preventive Nutrition 4 (1), 71-73, 2014 | 4 | 2014 |
| Cryptophycin F–A potential cyanobacterial drug for breast cancer M Sangeetha, M Menakha, S Vijayakumar Biomedicine & Aging Pathology 4 (3), 229-234, 2014 | 3 | 2014 |
| Lyngbyastatin 2-A Potential Drug for Brain, Gastric, Pros-tate and Ovarian Cancer M Sangeetha, M Menakha International Journal of Pharmaceutics and Drug Analysis 6 (2), 320-327, 2018 | 2 | 2018 |
| Molecular docking of bioactive compounds from Syzygium aqueum against type 2 diabetes susceptibility gene TCF7L2 P Mani, M Sridhar, M Sangeetha, E Motaro, R Vijayakumar International Journal of Pharmaceutics and Drug Analysis 6 (2), 271-278, 2018 | 2 | 2018 |
| Tasiamide-B a new cyanobacterial compound for treating skin cancer S Vijayakumar, M Menakha Biomedicine & Preventive Nutrition 4 (3), 355-358, 2014 | 2 | 2014 |
| Ideal drug for blood pressure D Praba, M Menakha, U Jeyanthi Int. J. Pharm. Sci. Rev. Res 25, 7-12, 2014 | 2 | 2014 |
| Combining molecular modelling and experimental approaches to gain mechanistic insights into the LuxP drug target in Streptococcus pyogens AS Alothaim, WA Alhoqail, M Menakha, R Vijayakumar Journal of Biomolecular Structure and Dynamics, 1-11, 2023 | | 2023 |
| Computational Design of New Analogues from Lyngbyastatin-2 against Epidermal Growth Factor Receptor (EGFR) through Molecular Docking R Vijayakumar, F Alfaiz, M Saleh Al-Aboody, M Sangeetha, M Menakha Journal of Pharmaceutical Research International 31 (6), 1-10, 2020 | | 2020 |
| Isolation and Identification of Potential Ligand Molecules from Glycyrrhiza glabra against EGFR by Molecular Docking VR Menakha M, Vinithra G, Sangeetha M, Al-Aboody M. S Biosc.Biotech.Res.Comm. 13 (1), 2020 | | 2020 |
| Comparativestudies of anti bacterial activity in AloeveraandAchyranthesasperaagainstwound pathogens EMRV Sangeetha M, Menakha S,P.Mani Internationaljournal ofpharmaceutics & drug analysis 6 (2), 286–289, 2018 | | 2018 |
| InstitutionalWasteWaterTreatment Using Root – Zone Method EMRV A.ShakilaPapanasam, M. Sangeetha,Menakha S, P.Mani Internationaljournal ofpharmaceutics & drug analysis 6 (2), 312–319, 2018 | | 2018 |
| Prediction of cyanobacterial drug for blood cancer through molecular docking VKS Menakha M,Sangeetha M International Journal of Current Advanced Research 6 (12), 8292-8296., 2017 | | 2017 |
| Identification of suitable drugs for oral candidiasis by molecular docking studies. MMMC Karthikeyan.K International Journal of Pharmaceutical Sciences Review and Research . 10 (2 …, 2011 | | 2011 |
